The Journal of Urology
Volume 159, Issue 6 , Pages 1885-1891 , June 1998

SUPERFICIAL BLADDER TUMORS AND INCREASED REACTIVITY AGAINST MYCOBACTERIAL ANTIGENS BEFORE BACILLUS CALMETTE-GUERIN THERAPY

,Accepted 14 November 1997.

REFERENCES 

  1. Lamm DL . Long-term results of intravesical therapy for superficial bladder cancer . Urol. Clin. N. Amer. . 1992;19:573
  2. Morales A , Eidinger D , Bruce AW . Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors . J. Urol. . 1976;116:180
  3. Bohle A , Gerdes J , Ulmer AJ , Hofstetter AG , Flad HD . Effects of local bacillus Calmette-Guerin in patients with bladder carcinoma on immunocompetent cells of the bladder wall . J. Urol. . 1990;144:53
  4. De Boer EC, De Jong WH, Steerenberg PA, Aarden LA, Tetteroo E, De Groot ER, et al. Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumor necrosis factor during intravesical immunotherapy with bacillus Calmette-Guerin in superficial bladder cancer . Cancer Immunol. Immunother. . 1992;34:306
  5. Ratliff TL , Ritchey JK , Yuan JJ , Andriole GL , Catalona WJ . T-cell subsets required for intravesical BCG immunotherapy for bladder cancer . J. Urol. . 1993;150:1018
  6. Pryor K, Goddard J, Goldstein D, Stricker P, Russel P, Golovsky D, et al. Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumor cell killing . Brit. J. Cancer. . 1995;71:801
  7. Thanhauser A, Bohle A, Schneider B, Reiling N, Mattern T, Ernst M, et al. The induction of bacillus Calmette-Guerin activated killer cells requires the presence of monocytes and T-helper type-1 cells . Cancer Immunol. Immunother. . 1995;40:103
  8. Hayward S, James K, Prescott S, Jackson AM, Ritchie ANS, Smyth JF, et al. The effects of recombinant human interferon-gamma on a panel of human bladder cancer cell lines . J. Urol. . 1991;145:1078
  9. Zlotta AR, Drowart A, Van Vooren JP, De Cock M, Pirson M, Palfliet K, et al. Evolution and clinical significance of the T-cell proliferative and cytokine response directed against the fibronectin-binding antigen 85 complex of bacillus Calmette-Guerin (BCG) during intravesical treatment of superficial bladder cancer . J. Urol. . 1997;157:492
  10. Zlotta AR, Drowart A, Huygen K, De Bruyn J, Shekarsarai H, De Cock M, et al. Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacillus Calmette-Guerin (BCG) in patients with superficial bladder cancer . Clin. Exp. Immunol. . 1997;109:157
  11. Minden P , McClatchy JK , Wainberg M , Weiss DW . Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells . J. Natl. Cancer Inst. . 1974;53:1325
  12. Bucana C , Hanna MG . Immunoelectronmicroscopic analysis of surface antigens common to Mycobacterium bovis (BCG) and tumor cells . J. Natl. Cancer Inst. . 1974;53:1313
  13. Huygen K , Van Vooren JP , Turneer M , Bosmans R , Dierckx P , De Bruyn J . Specific lymphoproliferation, gamma interferon production and serum immunoglobulin G directed against a purified 32kD antigen (P32) in patients with active tuberculosis . Scand. J. Immunol. . 1988;27:187
  14. Kaufmann SHE . Heat shock proteins and the immune response . Immunol. Today . 1990;11:129
  15. Dorken E , Grzybowski S , Allen EA . Significance of the tuberculin test in the elderly . Chest . 1987;92:237
  16. De Bruyn J , Bosmans R , Nyabenda J , Van Vooren JP . Effect of zinc deficiency on the appearance of two immunodominant protein antigens (32 kDa and 65kDa) in culture filtrates of mycobacteria . J. Gener. Microbiol. . 1989;135:79
  17. Multhoff G, Botzler C, Wiesnet M, Muller E, Meier T, Wilmanns W, et al. A stress-inducible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells but not on normal cells . Int. J. Cancer . 1995;61:272
  18. Ferrarini M , Heltai S , Zocchi MR , Rugarli C . Unusual expression and localization of heat-shock proteins in human cells . Int. J. Cancer . 1992;51:613
  19. Bruno S, Machi AM, Semino C, Meta M, Ponte M, Varaldo M, et al. Phenotypic, functional and molecular analysis of lymphocytes associated with bladder cancer . Cancer Immunol. Immunother. . 1996;42:47
  20. Luftenegger W, Ackerman DK, Futterlieb A, Kraft R, Minder CE, Nadelhalft P, et al. Intravesical versus intravesical plus intradermal bacillus Calmette-Guerin: a prospective randomized study in patients with superficial bladder tumors . J. Urol. . 1996;155:483
  21. Wiker HG , Harboe M . The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis . Microbiol. Rev. . 1992;56:648
  22. Content J , de la Cuvellerie A , De Wit L , Vincent-Levy-Frebault V , Ooms J , De Bruyn J . The genes encoding for the antigen 85-complex of M. tuberculosis and M. bovis BCG are members of a gene family: cloning, sequence determination and genomic organization of the gene coding for the antigen 85-C . Infect. Immunol. . 1991;59:3205
  23. Launois P, Niang MB, De Bruyn J, Sarthou JL, Rivier F, Drowart A, et al. The major secreted antigen complex (AG 85) from M. bovis bacille Calmette-Guerin is associated with protective T-cells in leprosy; a follow-up study of 45 household contacts . J. Infect. Dis. . 1993;167:1160
  24. Huygen K, Content J, Denis O, Montgomery DL, Yawman AM, Deck RR, et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine . Nature Med. . 1996;2:893
  25. Kaver I , Pecht M , Trainin N , Greenstein A , Braf Z . T lymphocyte substets and function in the peripheral blood of patients with urological cancer . Oncology . 1992;49:108
  26. Pansadoro V, Emiliozzi P, Donadio D, Florio A, Maurelli S, Lauretti S, et al. Bacillus Calmette-Guerin in the treatment of stage T1 grade transitional cell carcinoma of the bladder: long-term results . J. Urol. . 1995;154:2054
  27. Brown ST , Almenoff PL . Pulmonary mycobacterial infections associated with neoplasia . Sem. Respir. Infect. . 1992;7:104
  28. Haasz R , Robinson E . Lymphocyte reactivity in healthy subjects and cancer patients . Acta Haematol. . 1977;3:331

 Read at annual meeting of American Urological Association, New Orleans, Louisiana, April 12-17, 1997.

 Supported in part by Grants 3.0020.89 and 3.3000.91 from the NFWO (Belgian National Research Foundation).

PII: S0022-5347(01)63186-0

The Journal of Urology
Volume 159, Issue 6 , Pages 1885-1891 , June 1998

Article Tools

* Image Usage & Resolution